Paradigm
PrivateLast Round
Series B
Dec 4, 2025
Total Funding Raised
$281M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Paradigm Health is a healthcare technology company that provides an AI-powered clinical trial platform to connect biopharmaceutical sponsors with healthcare providers to streamline clinical research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Data Integration, Compliance, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradigm Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Paradigm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 4, 2025 | ||||
| Series A | Jan 25, 2023 |
Key People
Founding team and executive leadership
Paradigm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, Series B |
| ARCH Venture Partners | Series B |
| F-Prime Capital | Series A, Series B |
| Magnetic Ventures | Series A |
| OM Venture Capital | Seed |
| BrightEdge | Series B, Series A |
| Lux Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Partnered with the U.S. Food and Drug Administration to test a new data system.
- Dec 4, 2025
$78M Series B round completed.
Paradigm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paradigm's valuation, stock price, and market status.